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Abstract
Chlamydia trachomatis is an important human pathogen that replicates inside the infected
host cell in a unique vacuole, the inclusion. The formation of this intracellular bacterial niche
is essential for productive Chlamydia infections. Despite its importance for Chlamydia biolo-
gy, a holistic view on the protein composition of the inclusion, including its membrane, is cur-
rently missing. Here we describe the host cell-derived proteome of isolated C. trachomatis
inclusions by quantitative proteomics. Computational analysis indicated that the inclusion is
a complex intracellular trafficking platform that interacts with host cells’ antero- and retro-
grade trafficking pathways. Furthermore, the inclusion is highly enriched for sorting nexins
of the SNX-BAR retromer, a complex essential for retrograde trafficking. Functional studies
showed that in particular, SNX5 controls the C. trachomatis infection and that retrograde
trafficking is essential for infectious progeny formation. In summary, these findings suggest
that C. trachomatis hijacks retrograde pathways for effective infection.
Author Summary
The important human pathogen Chlamydia trachomatis causes 100 million new infections
each year world-wide. It replicates inside the infected host cell in a unique vacuole, the in-
clusion. Currently, the nature, and specifically the protein composition of the inclusion, is
poorly defined. Here, we described the host cell-derived inclusion proteome by quantita-
tive proteomics using a newly established method to purify inclusions from infected epi-
thelial cells. We showed that the inclusion is a complex intracellular trafficking platform
that is well embedded into the organellar network and interacts with host cells’ antero-
PLOS Pathogens | DOI:10.1371/journal.ppat.1004883 June 4, 2015 1 / 25
OPEN ACCESS
Citation: Aeberhard L, Banhart S, Fischer M,
Jehmlich N, Rose L, Koch S, et al. (2015) The
Proteome of the Isolated Chlamydia trachomatis
Containing Vacuole Reveals a Complex Trafficking
Platform Enriched for Retromer Components. PLoS
Pathog 11(6): e1004883. doi:10.1371/journal.
ppat.1004883
Editor: Michael N. Starnbach, Harvard Medical
School, UNITED STATES
Received: October 30, 2014
Accepted: April 14, 2015
Published: June 4, 2015
Copyright: © 2015 Aeberhard et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant proteome
data are available from the the proteomeXchange
database (http://www.proteomexchange.org/) at
accession number PXD002113.
Funding: This work was financially supported by the
Deutsche Forschungsgemeinschaft (www.dfg.de):
SPP 1580 to DH (HE6008/1-1 and HE6008/1-2) and
RE3474/2-1 to BYR. Federal Ministry of Education
and Research (BMBF) (www.bmbf.de) in the
framework of the national research network “Zoonotic
Chlamydia - Models of chronic and persistent
and retrograde trafficking pathways. Particularly, SNX1, 2, 5 and 6, components of the ret-
romer, are recruited to the inclusion and seem to control the infection. We found also that
retrograde trafficking is essential for Chlamydia progeny formation. Our study provides
new insights into how the obligate intracellular bacterium C. trachomatis interacts with
the eukaryotic host cell and subverts host cell functions for productive infection.
Introduction
With 100 million new infections per year, Chlamydia trachomatis is the most frequently sexually
transmitted bacterial pathogen world-wide [1]. C. trachomatis replicates inside a membrane-
bound vacuole, the inclusion, and has a unique cycle of development, alternating between two
distinct bacterial forms. The elementary body (EB) is spore-like, infectious but non-dividing. In
contrast, the reticulate body (RB) is non-infectious but replicative. After internalization of the
EB, the bacteria are found inside the inclusion, which is segregated from the lysosomal degrada-
tion pathway. EBs then differentiate into RBs, which replicate inside the growing inclusion. At
mid-infection time points the inclusion is packed with replicating RBs that start to re-differenti-
ate into EBs [2]. The surrounding inclusion membrane is the interface between the bacteria and
the host cell. This membrane is actively modified by insertion of bacterial proteins and is not
permissive for diffusion of molecules of 520 Da and larger [3]. It contains classical bacterial in-
clusion proteins of the Inc-protein family as well as non-classical Inc proteins [4]. Furthermore,
a growing number of cellular proteins have been described to associate with the Chlamydia in-
clusion, but a global picture of proteins contributing to the inclusion is currently missing.
Membranes compartmentalize the eukaryotic cell into different organelles, including those
of the secretory pathway and the endo-lysosomal system. In the secretory pathway, cargo is
modified to address it to and then to transport it to its designated destination. The endo-lyso-
somal system functions in internalization of molecules from the plasma membrane (PM) or
the extracellular space, followed by sorting of these molecules either for degradation in the ly-
sosomes or for retrograde transport to different organelles, including the Golgi apparatus
(GA). The human retromer is a multi-protein complex essential for recycling of cargo receptors
into the tubular endosomal network and transports them to the trans-Golgi network (TGN)
[5]. In human cells, the retromer consists of a membrane-deforming and a cargo recognition
subcomplex, which are composed of the sorting nexins (SNX) 1, 2, 5, 6 and the vacuolar pro-
tein sorting-associated proteins (VPS) 26, 29, 35, respectively [6]. On endosomes, SNX dimers
bind to phosphatidylinositol phosphates (PIPs) via their phox homology (PX)-domains. Addi-
tionally, these SNXs contain a Bin-Amphiphysin-Rvs (BAR) domain that recognizes mem-
branes with high curvature and induces membrane tubulation, which is thought to support
sorting of retrograde receptors out of the endo-lysosomal pathway [7]. Interaction with the
cargo recognition subcomplex eventually leads to vesicle formation and the enclosed cargo is
transported along microtubules to the TGN [8,9].
Proteomic studies of phagosomes isolated using latex-beads have greatly increased our
knowledge about the biogenesis and function of these organelles [10–12]. Furthermore, the
biochemical purification of vacuoles containing Salmonella enterica,Mycobacterium avium,
Rhodococcus equi and Legionella pneumophila also fostered our understanding of the host cell
protein composition of these unique intracellular compartments [13–17].
Here, we describe a two-step protocol for the isolation of high purity C. trachomatis serovar
L2 inclusions at mid-cycle. Using LC-MS/MS based proteomics combined with ss isotope label-
ing by amino acids in cell culture (SILAC), we identified 351 host cell proteins that are
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significantly enriched in the proteome of isolated inclusions, representing the host cell-derived
Chlamydia inclusion proteome. Enrichment analysis of this data showed that the C. trachomatis
inclusion is a complex intracellular compartment that interacts with components of the retro-
mer. Confocal studies confirmed the recruitment of SNX1, 2, 5 and 6 to the inclusion and fur-
ther suggested that the retromer subcomplexes are at least partially separated at the inclusion
membrane. Functional analyses of the retromer by RNA interference and by treatment with
Retro-2, an inhibitor of retrograde transport of toxins and viruses, revealed that knockdown of
SNX5 resulted in an increase in infectious progeny whereas Retro-2 treatment inhibited the for-
mation of infectious bacteria. Taken together, these results show a previously unknown associa-
tion of SNXs with C. trachomatis inclusions and provide evidence for a new role of SNXs during
bacterial infections that appears to be independent of the classical SNX-BAR retromer complex.
Results
Isolation of C. trachomatis inclusions from HeLa cells 24 h p.i.
We established an isolation method for C. trachomatis inclusions at mid-infection time points,
based on a two-step protocol originally described for the isolation of Legionella-containing vac-
uoles from amoebae (Fig 1A) [16]. Infected HeLa cells were lysed and the obtained cell lysate
containing inclusions was separated on a self-forming Percoll gradient. Gradient fractions were
taken and analyzed for presence of bacterial and cellular proteins by immunoblotting and for
presence of intact inclusions by phase contrast microscopy (S1A and S1B Fig). The high density
fractions harboring intact inclusions (S1A and S1B Fig) were collected, pooled and further pu-
rified by magnet assisted cell sorting (MACS) using an antibody specific for IncA, a bacterial
transmembrane protein located in the inclusion membrane [18]. Presence and numbers of in-
clusions were monitored by phase contrast microscopy (Fig 1A and 1B). Counting of visually
intact inclusions at each purification step showed that ~50% of C. trachomatis inclusions pres-
ent in the cell lysate could be isolated (Fig 1B). The purity of the different fractions was assessed
by immunoblotting, using antibodies specific for marker proteins of different cellular compart-
ments and for chlamydial proteins (Fig 1C). Lysate of infected and uninfected HeLa cells
showed presence of organelles such as the nucleus, endoplasmic reticulum (ER), lysosomes,
mitochondria, cytosol and the PM (Fig 1C). After separation by Percoll gradient, inclusions
were enriched as indicated by an increase in IncA and Hsp60 signals, accompanied by a de-
crease in signals for cellular compartments. MACS purification resulted in a fraction that con-
tained chlamydial inclusions that were nearly completely devoid of cellular contaminants as
monitored by immunoblotting (Fig 1C). Obtained inclusion fractions were then analyzed by
electron and fluorescence microcopy (Fig 1D and 1E). Transmission electron microscopy
(TEM) demonstrated the presence of inclusions that contained both bacterial forms sur-
rounded by the inclusion membrane (Fig 1D). To validate the presence of cellular proteins in
the isolated inclusion fraction, inclusions were purified from cells expressing a Rab11A-eGFP
fusion protein that is known to be associated with C. trachomatis inclusions [19]. Immunofluo-
rescence (IF) staining and confocal microscopy of isolated inclusions revealed that Rab11A-
eGFP signal co-localized with IncA in a rim-like pattern (Fig 1E). In summary, these data show
that we are able to isolate C. trachomatis inclusions at mid-infection time points.
Identification of inclusion-associated, cellular proteins by quantitative
proteomics
To identify host cell proteins specifically associated with isolated C. trachomatis inclusions,
SILAC was applied [20]. Using this method, we were able to control for non-specific, co-
Quantitative Proteomics of Chlamydia Inclusions
PLOS Pathogens | DOI:10.1371/journal.ppat.1004883 June 4, 2015 3 / 25
purifying proteins during the isolation procedure (Fig 2A). The proteins that are bona fide con-
stituents of the inclusion were expected to have a high ratio of L label vs. H label (SILAC ratio)
of one peptide species, whereas contaminants were expected to have SILAC ratios close to 1 in
the inclusion fraction (Fig 2A). The abundance of inclusion-associated proteins in enriched
fractions and proteins in total cell lysates was calculated using iBAQ (intensity based absolute
quantification) which estimates the abundance of proteins based on the sum of peak intensities
of all peptides matching to a specific protein, divided by the number of theoretically observable
peptides [21]. Despite limited accuracy, this method provides additional information especially
Fig 1. Isolation ofC. trachomatis inclusions from HeLa cells at 24 h p.i. A) Workflow of the MACS purification procedure. Inclusions were isolated from
C. trachomatis L2 infected cells. Different fractions of the purification procedure were analyzed by phase contrast microscopy. B) Visually intact inclusions
were counted in different fractions (n = 3; error bars, SD). C) Immunoblot analysis of different steps of the inclusion purification procedure. In the first three
fractions, equal volumes of approximately equal protein amounts were loaded, the MACS 5X lane contains 5X the number of inclusions contained in the
infected cell lysate lane. The indicated proteins were detected with specific antibodies. The subcellular compartments indicate the primary location of the
probed proteins. D) TEM of gradient purified and washed inclusions. IM, inclusion membrane; EB, elementary body; RB, reticulate body. E) Inclusions were
gradient purified from C. trachomatis L2 infected HeLa cells transiently expressing Rab11A-eGFP, fixed, immunostained with IncA antibodies (red) and
analyzed using LSCM. The DNA was stained with DAPI (blue). Scale bar, 2 μm; n = 2. See also S1 Fig.
doi:10.1371/journal.ppat.1004883.g001
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for highly abundant proteins in addition to the SILAC based exclusion approach. Based on this
method, we quantified the relative contribution of each protein to the total proteome of the ly-
sate and the inclusion using sum total normalization for the proteins in each fraction. Only
proteins that passed the SILAC exclusion approach were considered for the inclusion prote-
ome. The quotient of the values for the inclusion and the lysate resulted in the enrichment
score for proteins which were overlapping in the two datasets (iBAQ enrichment score) (Fig 2B
and S1 Text). For proteins that were not found in our lysate proteome, we used a recently pub-
lished very high coverage dataset of the HeLa proteome [22] for approximation of the protein
abundance in the cell lysate. We performed experiments in three biological replicates. Analysis
of the raw data by MaxQuant resulted in the identification of 1400 host cell proteins in the in-
clusion fraction (Fig 2C) and 2002 host cell proteins in the cell lysate. To characterize potential
organellar contaminants, subcellular localization data of all proteins in the inclusion fraction
was retrieved from UniprotKB [23] and annotations were plotted according to their SILAC ra-
tios (Fig 2D). This data clearly showed that proteins from mitochondria, the nucleus and the
PM appeared at SILAC ratios of 1 and lower, and therefore are most likely contaminants of the
inclusion fraction. The majority of proteins annotated with the terms cytoplasmic vesicle, ER,
ER-Golgi intermediate compartment (ERGIC), GA and lysosome were separated from the con-
taminants with a SILAC ratio above 1.5, demonstrating an enrichment of these proteins in the
inclusion isolation procedure of infected cells vs. uninfected cells (Fig 2D). Statistical testing
based on the SILAC ratio distribution in the lysate and in the inclusion fractions revealed 351
host proteins that were significantly enriched in the inclusion fraction, of which 253 were high-
ly reliable due to the presence of high ratios in all three replicates, resulting in small multiplicity
adjusted p values of below 0.01 (S2A Fig). An additional 98 proteins were qualified as enriched
with reduced statistical confidence (multiplicity adjusted p value< 0.05, S2B Fig). These 351
host proteins are thus considered to be inclusion associated (S1 Table). Of the approximately
50 host proteins known to be recruited to Chlamydia inclusions, 23 were identified in our anal-
ysis (S2 Table). These proteins included 14-3-3 ß, CERT, VAP-A, VAP-B, Rab1, Rab6A,
Rab11A and Rab14 [19,24–27]. These known inclusion-associated proteins were distributed
across the SILAC ratios, further increasing our confidence in the generated inclusion proteome
data set (Fig 2C).
We next validated the obtained data by confocal microscopy. To this end, 26 newly found
inclusion-associated proteins with different SILAC ratios were chosen. Proteins of interest
were either detected after ectopic expression of tagged fusion proteins or by visualizing endoge-
nous proteins using specific antibodies (S3 and S4 Figs). Non-fused eGFP was used as control.
Localization of these proteins in infected cells was assessed after IF staining counterstained
with an IncA-specific antibody to visualize the inclusion membrane and were then analyzed by
Fig 2. Quantitative proteomics of isolatedC. trachomatis inclusions. A) Workflow of inclusion host proteome analysis. The scheme of three different
peptides (1–3) measured by LC-MS/MS shows idealized SILAC ratios for peptides derived from different classes of proteins. (1) Ideal inclusion associated
protein. Contaminations are expected to be identical for H and L labeling, corresponding to peptide (2). Proteins that are in part contaminations as well as
inclusion associated have a lower L/H ratio (3). The enrichment of proteins in the inclusion fraction compared to the total lysate is calculated based on
intensity based absolute quantification (iBAQ). B) The iBAQ enrichment score was calculated by dividing the proportional amount of protein specifically
associated with the inclusion by the amount of this protein in the total lysate fraction. For more details see main text and S1 Text. C) Each protein identified
and quantified in triplicate was plotted with its SILAC ratio (grey lines, lin/log plot). Known (green lines) and newly validated proteins (blue, yellow and red
lines) are indicated. D) Distribution of annotated organellar proteins along the SILAC ratios. Mean SILAC ratios of proteins were pooled into bins of 0.125
(n = 1400). The total number of proteins mapping to the subcellular localization term was determined and the percentage in each bin plotted along against the
SILAC ratios. Data points were connected for better visibility. SILAC ratios of 3 and above were pooled in the 3+ bin. Dashed line, approximate cutoff for
enrichment. E) Validation of inclusion associated proteins using fluorescent fusion proteins. Confocal IF images showing HeLa cells expressing the indicated
fluorescent fusion proteins (green), infected with C. trachomatis L2 (MOI 2). Cells were fixed 24 h p.i. and stained for inclusion membrane (IncA red) and DNA
(DAPI, blue). Scale bar, 20 μm. F) Validation by purified inclusions. Inclusions were gradient purified from cells expressing the indicated fusion protein using a
small scale protocol and analyzed by LSCM, DNA was stained with DAPI. Scale bar, 5 μm. For supplemental data see S2–S4 Figs.
doi:10.1371/journal.ppat.1004883.g002
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laser scanning confocal microscopy (LSCM) (Figs 2E and S3 and S4). To confirm the presence
of the fluorescently tagged proteins in the inclusion fraction, inclusions were also isolated from
cells transiently expressing the respective fusion proteins (Figs 2E and S3). In total, 26 proteins
were included in the validation process. From these 26 proteins, 19 proteins were validated
positively, either by inclusion isolation or by immunofluorescence microscopy. Among these
positive hits were YFP-RAB3D wild-type, VCP-eGFP, eGFP-SYNGR2, eGFP-Rab8A,
GFP-Syntaxin 7, STIM1 and Sec22b. As expected, no co-localization of eGFP was observed (S3
Fig). Five proteins were evaluated as false-positive including eGFP-Cofilin-1, Sequestosome-1
and Arginase-1 (S3 and S4 Figs). For two proteins the localization to the inclusion as moni-
tored by fluorescence microscopy was ambiguous (S3 and S4 Figs). Furthermore, recruitment
of Rab3D appears to be an active process, as the dominant negative form of Rab3D
(YFP-RAB3D T36N) was not found at the inclusion (Fig 2E). Taken together, we have identi-
fied 351 host cell proteins that are significantly enriched in the isolated inclusion fraction and
thus contribute to the host cell-derived inclusion proteome.
Global analysis of the host cell-derived inclusion proteome reveals a
complex intracellular compartment enriched for retromer components
Based on this core host cell-derived inclusion proteome, we analyzed the contribution of cellu-
lar organelles to the proteome of isolated inclusions. Subcellular localization data of the identi-
fied proteins was retrieved from UniprotKB to calculate the relative contribution of different
organelle types to the obtained proteomes. We observed a clear enrichment of proteins anno-
tated as components of the ER, the PM, the ERGIC, the GA, endosomes and cytoplasmic vesi-
cles (Fig 3A). As expected, relative depletion was seen for proteins annotated as nuclear and
mitochondrial (Fig 3A).
Next, we performed a gene ontology (GO) enrichment analysis based on GO of biological
processes (GOBP) (S3 Table). The most highly enriched single term apart from ER-specific
processes was `establishment of protein localization´ (GO:0045184) with a p value of 3.94 x
10–13 and a total of 86 proteins contributing to this category. Proteins from this term were ana-
lyzed for specific complexes of interacting proteins using STRING 9.1 [28]. This interaction
map revealed four clusters of highly interacting proteins including a cluster composed of the
SNX-BAR retromer, a complex involved in retrograde trafficking from endosomes to the TGN
(Fig 3B). The most granular (i.e. highly resolved) GO term apart from ER-related processes
was `vesicle-mediated transport´ (p = 1.66 x 10–10, GO:0016192, n = 58; n = 72 including child
terms). To further characterize these trafficking pathways that are putatively involved in the
function of the inclusion, we analyzed the contribution of proteins involved in anterograde and
retrograde transport to the proteome (Fig 3C). Proteins involved in retrograde trafficking con-
stitute 39% of these proteins, with retrograde transport from endosomes to the GA being the
largest group within the retrograde trafficking group (17% of total). Strikingly, components of
the human retromer were highly enriched in the host cell-derived inclusion proteome com-
pared to total cell lysates, including proteins of the SNX family and the retrograde-transport
cargo protein Ci-M6PR, which are among the 25% most highly enriched proteins (Fig 3D). In
summary, the host cell-derived proteome of C. trachomatis inclusions reveals a complex intra-
cellular compartment enriched for SNX-BAR retromer and suggests that the inclusion interacts
with multiple cellular trafficking pathways, including this retrograde transport pathway.
SNXs are recruited to the C. trachomatis inclusion
Based on the high enrichment of retromer components on C. trachomatis inclusions, we per-
formed IF studies using antibodies specific for SNX1, SNX2, VPS35 and Ci-M6PR to confirm
Quantitative Proteomics of Chlamydia Inclusions
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localization of these proteins to the inclusion using LSCM (Figs 4A and S5A). SNX5 and SNX6
localizations were analyzed after ectopic expression of eGFP-SNX fusion proteins (Figs 4B and
S5B). In uninfected HeLa cells, signals for SNX1 and SNX2, were found in punctuated struc-
tures in the cytosol consistent with the reported endosomal localization of these SNXs (S5A
Fig). In contrast, in C. trachomatis-infected HeLa cells, SNX1, SNX2, eGFP-SNX5 and
eGFP-SNX6 were detected as a rim-like staining pattern that partially co-localized with the
bacterial inclusion marker, IncA (Fig 4A and 4B). Recruitment of these SNXs was specific, as
other members of the SNX family (SNX3 and SNX12) did not co-localize with the inclusion
membrane (S6 Fig). Furthermore, these SNXs were also found in IncA-positive fibers emanat-
ing from the inclusion body (Fig 4C). Interestingly, VPS35 and Ci-M6PR did not show a rim-
like inclusion-staining pattern, but rather were depicted as small punctuated structures adja-
cent to the inclusion, suggesting that the membrane-deforming and receptor-recognition sub-
complex of the human retromer are at least partially disconnected at the inclusion (Fig 4A). To
confirm the separation of these two subcomplexes, SNX2 and VPS35 were simultaneously lo-
calized in infected and uninfected cells (Figs 4D and S7). Interestingly, at the inclusion, a sepa-
ration of the two signals was observed. Co-localization of the two signals in defined punctuated
structures at the inclusion was rarely seen (Fig 4D). In contrast, in uninfected cells, signals for
both subcomplexes were clearly co-localized (S7 Fig). Pearson's correlation coefficient also sug-
gested only a moderate co-localization of the two signals at the inclusion, whereas a strong cor-
relation was detected in punctuate-structures in the cytoplasm of either infected or uninfected
cells (S7 Fig). To avoid artifacts due to overexpression of eGFP-SNX2, we also performed ex-
periments in cells expressing eGFP-VPS35 and stained for endogenous SNX2 (S7B Fig), con-
firming that the retromer subcomplexes do not co-localize at the inclusion, indicating
separation or dissociation of the retromer complex. No difference in protein abundance for all
tested retromer components was detected in C. trachomatis-infected cells compared to control
cells (Fig 4E). These observations demonstrate that during C. trachomatis infection SNX-BAR
proteins become recruited to the inclusion and the localization of the two retromer subcom-
plexes is dramatically changed.
Silencing of SNX5 promotes C. trachomatis infectious progeny
formation
Given that SNX-BAR proteins of the retromer are recruited to the C. trachomatis inclusion at
24 h p.i., we tested whether knockdown of retromer components by RNA interference (RNAi)
affects C. trachomatis infection including inclusion formation and development of infectious
EBs. We used pools of small-interfering RNAs (siRNAs) to target SNX1, 2, 5 and 6. Silencing
of these proteins did not affect the formation of inclusions as analyzed by inclusion size and
numbers (Fig 5A and 5B). Interestingly, silencing of SNX5 resulted in a clear increase in
Fig 3. Global analysis of the host cell derived inclusion proteome. A) Proteins that were reliably found and quantified in the inclusion proteome or the
total cell lysate were annotated with subcellular localization data from UniprotKB. Proteins were quantified according to their iBAQ intensity and the
abundance of proteins annotated with the indicated term was summed. One protein can have annotations for several categories and organelles. B) Protein-
protein interactions of inclusion associated proteins annotated with the highly enriched GO term `establishment of protein localization´. Connecting lines
indicate interactions as reported by STRING database in standard settings. Color of the node represents the enrichment score, the color of border of the
nodes are colored according to the SILAC ratio. Main clusters of interacting proteins are encircled with a green line and labeled I-IV. C) Proteins annotated
with the GO term `vesicle mediated transport´ were further classified as involved in retrograde or anterograde transport (n = 35) and respective
subcategories. Three proteins with incomplete GO annotation were added manually (Rab1B, Rab12, VPS29). Five proteins were annotated with both
retrograde and anterograde transport pathways (LMAN1, Rab11B, Rab14, TMED10 and VAMP3). Two additional proteins were annotated with two
subcategories (Stx7, VAMP8, both anterograde). E = endosome, ER = endoplasmic reticulum, GA = Golgi apparatus, EX = exocytosis, PM = plasma
membrane, LY = lysosome, RE = recycling endosome. D) Enrichment of proteins at the inclusion calculated using iBAQ. Each protein is represented by a line
colored according to its enrichment score. Black lines indicate the ranges of log2 transformed fold enrichment. Proteins of interest, white lines. For
supplemental data see S15 Fig.
doi:10.1371/journal.ppat.1004883.g003
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infectious EBs compared to control transfections (Fig 5C). SNX1, 2 and 6 knockdown also in-
creased infectious progeny, albeit only marginally (Fig 5C). Genome copy numbers upon si-
lencing of the different SNX proteins were slightly affected, showing the strongest increase in
genome copy numbers in SNX5 knockdown cells (Fig 5D). Immunoblotting confirmed that
upon knockdown, the targeted SNX-BAR proteins were drastically reduced compared to con-
trol treated cells (S8A Fig). We confirmed published data that silencing of SNX5 also resulted
in a decrease in protein level of SNX1 (S8A Fig). To elucidate if the observed increase in infec-
tious progeny in SNX5 knockdown cells is dependent on co-regulating the abundance of the
other SNX proteins, we silenced SNX5 in combination with SNX1, 2 or 6 and measured
Fig 4. C. trachomatis infection shows SNX recruitment to the inclusion and leads to partial separation of the retromer subcomplexes. A) Confocal
IF images showing localization of retromer components duringC. trachomatis L2 infection (MOI 1). HeLa cells were fixed 24 h p.i. and stained with indicated
antibodies; DNA was stained with DAPI (blue). Scale bar, 5 μm; n = 3. B) Confocal IF images showing localization of eGFP fusion proteins of SNX5 and
SNX6 recruited to the inclusion. HeLa cells were infected with C. trachomatis L2 (MOI 2) 4 h prior to transfection, fixed at 24 h p.i. and stained with indicated
antibodies; DNA was stained with DAPI (blue). Scale bar, 10 μm; n = 2. C) Confocal IF images showing fibers positive for SNX1 and IncA in C. trachomatis L2
infected HeLa cells (MOI 2). Cells were fixed at 24 h p.i. and stained with indicated antibodies; DNA was stained with DAPI (blue). Images show a maximum
intensity projection of a z-stack, arrows indicate SNX1/IncA fibers. Scale bar, 10 μm; n = 3. D) Confocal IF images showing co-localization of eGFP-SNX2
fusion protein with endogenous VPS35 inC. trachomatis L2 infected (Ctr L2, MOI 2) and uninfected (NI) HeLa cells. HeLa cells were infected 4 h prior to
transfection, fixed at 24 h p.i. and stained with indicated antibodies; DNA was stained with DAPI (blue). Scale bar, 10 μm; n = 2. E) Immunoblots of retromer
components duringC. trachomatis L2 infection (MOI 2) at 24 h p.i. n = 2. For supplemental data see S5–S7 Figs.
doi:10.1371/journal.ppat.1004883.g004
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infectious progeny formation (S8B Fig). Number of infectious bacteria was increased under all
combinational knockdown conditions compared to control, suggesting that other SNX pro-
teins do not contribute to the observed increase in infectious progeny formation in SNX5
knockdown cells. Knockdown efficiencies in these double knockdown cells were confirmed by
immunoblotting (S8A and S8C Fig). Taken together, these results suggest that individual
Fig 5. Silencing of SNX5 promotesC. trachomatis infectious progeny formation. A) Confocal IF images showingC. trachomatis L2 infected (MOI 0.5),
siRNA-treated HeLa cells. Cells were transfected with siRNA pools against indicated genes or control siRNA (AllStars), fixed at 24 h p.i. and stained with
indicated antibodies; DNA was stained with DAPI (blue). Scale bar, 50 μm; n = 2. B) Analysis of the primary infection in siRNA-treated HeLa cells from panel
A. Inclusions and nuclei were microscopically counted in 5 fields of view and ratio was calculated (n = 2; error bars, SE). C) Reinfection assay assessing the
effect of SNXs knockdown on infectious progeny formation 48 h p.i. n = 3; error bars, SE; *** indicates p value < 0.005. D) Graph showing the effect of SNXs
knockdown on relative bacterial genome copy number in C. trachomatis L2 infected (Ctr L2, MOI 0.5) HeLa cells at 48 h p.i. Genome copy number was
determined by qRT-PCR (n = 2; error bars, SE). For supplementary data see S8 Fig.
doi:10.1371/journal.ppat.1004883.g005
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SNX-BAR proteins might have distinct functions in addition to controlling the retrograde
transport of specific receptors. SNX5 in particular might be a rate-limiting factor and involved
in intracellular replication of C. trachomatis, most likely independently of the other SNX-BAR
retromer components.
Retro-2 treatment reduces infectious progeny formation of C.
trachomatis
Retro-2 was identified in a high-throughput screen for small molecules that inhibit the toxicity
of the plant toxin ricin in cell culture and was additionally found to efficiently protect cells
from secreted bacterial toxins, including Shiga-like toxin and cholera toxin by inhibiting retro-
grade trafficking of these toxic agents from the endosomes to the GA or the ER without affect-
ing trafficking of endogenous cellular retrograde-transport cargo proteins including Ci-M6PR
[29].
SNX1, SNX2 and eGFP-SNX5 recruitment to the inclusion was detected starting from 12 h
p.i. Interestingly, association of eGFP-SNX6 with the inclusion was detected slightly later (S9
Fig). At 16 h p.i. all inclusions were positive for the four different SNX proteins, coinciding
with the expansion of the inclusion (S9 Fig). Taking this into account, we treated cells prior to
SNX recruitment (8 h p.i.) with different concentrations of Retro-2 and assessed the formation
of infectious EBs by re-titration at 48 h p.i. Treatment of C. trachomatis-infected cells with
Retro-2 resulted in a dose-dependent decrease by more than one order of magnitude in EB
numbers compared to the vehicle control (Fig 6A). Reducing the treatment duration from 40 h
to 28 h by shifting the time point of Retro-2 addition to 20 h p.i. still showed a decrease in in-
fectious progeny formation albeit to a much lesser extent (S10 Fig). The progression of the
chlamydial developmental cycle was not affected as EB formation peaked at 48 h p.i. under
both conditions, even though fewer EBs were recovered from the Retro-2 treated sample (Fig
6B). Retro-2 treatment reduced the size of C. trachomatis inclusions at 24 h and 48 h p.i. by
about 40% without changing the shape of the inclusions (S11 Fig). Pretreatment of EBs with
high Retro-2 concentrations (200 μM) before infection did not reduce infectious progeny com-
pared to vehicle control (Fig 6C) and numbers of bacterial genomes were only slightly affected
by the inhibitor (Fig 6D). To elucidate the effect of Retro-2 treatment on induction of chlamyd-
ial persistence, the ultrastructure of Retro-2 treated and control infected cells were determined
by electron microscopy (Fig 6E). No signs of persistence in Retro-2-treated infections, as char-
acterized by the appearance of larger aberrant Chlamydia forms were observed. Quantification
of bacterial numbers confirmed that Retro-2 treatment affects replication of the bacteria which
is in agreement with Retro-2 effects on genome copy numbers (S12 Fig and Fig 6D). Interest-
ingly, we also detected a slight increase in numbers of intermediate bodies and ghosts in C. tra-
chomatis inclusion grown in Retro-2 treated cell cultures compared to solvent control (S12
Fig).
A recovery assay in which infected cells were treated with Retro-2 from 8–48 h p.i., followed
by removal of the inhibitor and additional incubation for 48 h in the absence of the inhibitor,
confirmed that Retro-2 does not induce chlamydial persistence (Fig 6F). These experiments
demonstrated that treatment of C. trachomatis infected cultures with Retro-2 strongly reduced
the number of infectious bacteria at 48 h p.i. and upon removal the number of infectious bacte-
ria remained on a low level. In contrast, the bacteria nearly completely recovered after removal
of the well-known persistence inducer, penicillin G (Fig 6F).
In summary, our data show that C. trachomatis infections are Retro-2 sensitive resulting in
smaller inclusions with slightly less bacteria inside, but with a strong defect in the generation of
infectious EBs without induction of persistence.
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We have shown that SNX5 and Retro-2 act on C. trachomatis infections, albeit with oppo-
site effects on the bacteria. To further determine which effect is dominant, cells were treated
with siRNA pools specific for SNX5, SNX1 and luciferase. Luciferase was used as non-targeting
control while SNX1 knockdown served as additional control, as it did not significantly increase
the EB numbers (Fig 5C). Infected knockdown cells were either treated with a single dose of
Retro-2 at 8 h p.i. or mock-treated. Infectious progeny number was determined 48 h p.i. (Fig
6G). As expected, in vehicle-treated SNX5 knockdown cells, the characteristic increase in EB
numbers upon knockdown of SNX5 was observed (Fig 6G). Interestingly, this increase in EB
numbers in comparison to SNX1 knockdown and non-targeting control was lost upon Retro-2
treatment (Fig 6G). To assess whether Retro-2-sensitive retrograde transport is involved in re-
cruiting SNX proteins to the inclusions, the localization of SNX proteins after Retro-2 treat-
ment was analyzed at 12 h, 16 h and 24 h p.i. by confocal microscopy. In these imaging studies,
no change in SNX localization was observed (S13 Fig). These data show that the increase in
numbers of infectious EB after the silencing of SNX5 is Retro-2 sensitive whereas recruitment
of SNX proteins to the inclusion appears to be Retro-2 insensitive.
Discussion
The previous inability to isolate Chlamydia inclusions enforced severe experimental constraints
and impeded progression in our comprehension of virulence mechanisms and the develop-
ment of novel anti-chlamydial therapies. For example, recruitment of cellular proteins to the
inclusion could only be addressed by microscopy. Direct biochemical evidence for the associa-
tion of these factors with the inclusion membrane was therefore missing. To overcome this lim-
itation, we established a method to isolate C. trachomatis inclusions at 24 h p.i. and analyzed
isolated inclusions using a quantitative proteomics approach to decipher the host-derived C.
trachomatis inclusion proteome.
We used the recently described protocol for the isolation of LCV from D. discoideum [16] as
a starting point, but due to the fragile nature of the C. trachomatis inclusion, this protocol was
heavily modified. As a result, we retained a two-step protocol but started with a Percoll-based
gradient followed by immuno-magnetic separation using an IncA-specific antibody. One of the
critical steps in the isolation protocol was the lysis of the infected host cells. We carefully tested
different buffer and infection conditions, but the majority of inclusions were ruptured at this
step resulting in a maximum recovery of 15% of the calculated initial numbers of inclusions.
The yield in the following steps (gradient and MACS) was about ~50% amounting to a total re-
covery rate of about 8%. This recovery rate is in the range or even slightly higher than the yields
obtained for Legionella containing vacuole isolations [16,30]. The second challenge was to find
an optimal strategy for initial purification of the visually intact inclusions from cellular debris.
Fig 6. Retro-2 reduces infectious progeny formation ofC. trachomatis. A) to C) Reinfection assays assessing the effect of Retro-2 on infectious progeny
formation. HeLa cells were infected withC. trachomatis L2 (MOI 2) and, at 8 h p.i., cells were either treated with indicated concentrations of Retro-2 or DMSO.
Cells were harvested and inclusion forming units (IFU) per ml were determined A) at 48 h p.i. (n = 3; error bars, SE; *** indicates p value < 0.005) or B) at
different time points after infection (n = 3; error bars, SE). C) C. trachomatis EBs were treated with 200 μMRetro-2 or DMSO as solvent control for 30 minutes
at room temperature before pelleting, followed by washing and infection of HeLa cells at MOI 2 for 48 h (n = 4; error bars, SE). D) Graph showing the effect of
Retro-2 on relative bacterial genome copy number inC. trachomatis L2 infected (MOI 2) HeLa cells at 24 h and 48 h p.i. Cells were infected and, at 8 h p.i.,
either treated with indicated concentrations of Retro-2 or DMSO as solvent control. Genome copy number was determined by qRT-PCR (n = 4; error bars,
SE; *** indicates p value < 0.005). E) TEM ofC. trachomatis L2 infected (Ctr L2, MOI 2) HeLa cells at 48 h p.i. treated with indicated concentrations of Retro-
2 or DMSO. G = ghost, IB = intermediate body, RB = reticulate body, EB = elementary body. Scale bar, 1 μm (upper micrographs) and 500 nm (lower
micrographs). F) Reinfection assay demonstrating the recovery of infectious progeny after treatment with Retro-2 and PenG. HeLa cells were infected and
treated with the indicated compound from 8 h p.i (Retro-2) or 24 h (PenG) until 48 h p.i. Cells were washed with fresh infection medium and incubated until 96
h p.i. to allow for recovery of the bacteria (n = 3, error bars = SE). G) Reinfection assay assessing the effect of Retro-2 and SNX knockdown on infectious
progeny formation. HeLa cells were transfected with siRNA pools against indicated genes or control siRNA (against Luciferase), infected withC. trachomatis
L2 (MOI 2), treated with Retro-2 at 8 h p.i., harvested at 48 h p.i. for reinfection assay (n = 2; error bars, SE).
doi:10.1371/journal.ppat.1004883.g006
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We used isopycnic density gradient centrifugation to separate inclusions from host cell debris.
We recovered the majority of inclusions in solution by fractionation of the gradient, but appar-
ently the buoyant density of inclusions is very diverse, distributed across the range of densities
of intracellular organelles, thus a subpopulation escaped our analysis which was distributed
over the whole gradient without apparent peaks. It seems likely that these are inclusions that ei-
ther contained large amounts of glycogen [31] or lipid droplets which are known to be translo-
cated into the lumen of inclusions [32]. This translocation could have a considerable effect on
their overall density. This speculation is supported by the absence of markers for lipid droplets
in our proteome analysis. Moreover, we detected inclusions ranging in size from 3 μm up to
10 μm, representing the majority of expected inclusion sizes, possibly with a slight bias towards
smaller inclusions, which could result from an increased fragility of larger inclusions.
The high sensitivity of modern LC-MS/MS-based proteomics demands an experimental de-
sign which includes a strategy to distinguish between bona fide components of the isolated
compartment as well as co-purified contaminations. To this end, we used a SILAC-based exclu-
sion approach in combination with label-free absolute quantification. A similar method was
successfully used in a recent study to identify contaminants in purified latex bead-containing
phagosome preparations [33].
Underlining the success of the purification and SILAC exclusion approach, we found a sig-
nificant proportion of previously reported inclusion-associated proteins in our dataset. To fur-
ther investigate the sensitivity of our assay, we ranked the proteins detected in a deep proteome
of HeLa cells [22] by the iBAQ value of tryptic peptides, to see if highly abundant proteins are
over-represented in the overlap with previously known inclusion-associated proteins (S14 Fig).
Our limit for reliable detection of proteins with more than one peptide is slightly above the me-
dian iBAQ intensity in the HeLa cell lysate (S14 Fig). This is satisfying, considering the techni-
cal difficulties due to massive amounts of bacterial peptides present in our samples. However,
based on these data, the true number of inclusion-associated proteins might be significantly
higher than what we report here, probably around two times greater than the reported number
based on known host proteins associated with inclusions. Furthermore, the SILAC exclusion
approach has also some limitations, for example with proteins that have a high dissociation
constant, which reduces the SILAC ratio due to exchange of L- for H-labeled proteins during
the extended incubation time in cell lysate before MACS separation, thereby increasing the
number of false negative classifications. These factors influence the number of reported pro-
teins, but are all likely to reduce the reported number rather than to lead to false positives.
Whereas originally the inclusion was thought to be a separated compartment that acts as a
niche devoid of host proteins [34], this picture has changed dramatically in recent years as indi-
cated by the extensive interaction with cellular organelles and recruitment of specific proteins,
often mediated by bacterial effectors, which was first described for 14-3-3 ß [27]. Interestingly,
proteins annotated as nuclear, mitochondrial and lysosomal were significantly depleted in the
Chlamydia inclusion proteome. Proteins assigned to other cellular organelles contributed sig-
nificantly to the inclusion proteome, suggesting the inclusion is embedded in the intracellular
trafficking network of the host cell. This conclusion supports the view that the C. trachomatis
inclusion is a complex intracellular trafficking platform that exploits different pathways to fos-
ter optimal intracellular growth, rather than that of an isolated niche. For an obligate intracel-
lular pathogen that lacks a number of genes for the biosynthesis of essential nutrients, this
integration into the host cell organellar network seems reasonable to secure intracellular sur-
vival [35]. We noted redundancy in interactions which could reflect robustness of the intracel-
lular lifestyle, which is further supported by the fact that C. trachomatis can infect and grow in
an array of different cell types.
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Detailed analysis of the host cell-derived inclusion proteome showed that C. trachomatis in-
clusions interact with the retromer, an important complex regulating retrograde transport of
different cellular receptors and a pathway also hijacked by bacterial and plant toxins and dis-
tinct viruses to intoxicate and infect cells [6,36–38]. In Chlamydia-infected cells, the SNX-BAR
proteins SNX1, 2, 5 and 6, are recruited to the inclusions decorating the inclusion in a rim-like
staining pattern and are additionally found on IncA-laden fibers emanating from the inclusion
body. In this context, it is interesting to note that Salmonella enterica serovar Typhimurium ac-
quire SNX1 and SNX3, and SNX1 is found on spacious vacuole-associated tubules early in the
infection process [39,40]. In uninfected cells, the PX and BAR domains of SNX-BAR proteins
target these proteins to phosphoinositide-enriched, high-curvature membranes [41,42]. Phos-
phatidylinositol-4-phosphate (PI4P) has also been detected in the inclusion membrane by ex-
pression PIP-sensitive reporter proteins [43]. Whether the detected PI4P or additional
bacterial proteins such as Inc proteins that are present in the inclusion membrane are involved
in recruiting the SNX-BAR proteins to the inclusions is currently not known. Interestingly, the
cargo recognition subcomplex of retromer showed only a punctual localization at the inclusion
membrane. Consequently, there is partial separation of the two retromer subcomplexes at the
inclusion membrane but not in other locations of infected cells. These observations support re-
cent findings on the structure and function of the cellular retromer. Firstly, whereas the retro-
mer complex is a stable hetero-pentamer in yeast cells, this association is much more transient
in mammalian cells [44] and secondly, the two subcomplexes and the individual SNX-BAR
proteins are involved independently of each other in trafficking of distinct cargo [45–47].
Functional analysis of SNX-BAR proteins using RNAi showed that in particular SNX5 knock-
down resulted in an increase in infectious progeny. This may indicate that SNXs, and in partic-
ular SNX5, become segregated by recruitment to the C. trachomatis inclusion, thereby affecting
the cellular retrograde trafficking pathways. The activity of the retromer complex has often
been linked to processes controlling the sorting of cellular receptors including the epidermal
growth factor receptor (EGFR) and M6PR [48,49]. SNX5 in particular has been implicated in
EGFR trafficking and signaling in uninfected cells [48]. For C. trachomatis infections it has re-
cently been demonstrated that EGFR activity is important for maturation of the inclusion by
controlling calcium signaling and actin remodeling [50]. In light of these and our findings it is
tempting to speculate that SNX5 recruitment to the inclusion alters e.g. EGFR transport and
signaling inside the cells which in turn triggers calcium release and F-actin rearrangements.
These changes then support the development of a proper C. trachomatis inclusion and are thus
important for a successful infection. Alternatively, distinct SNX-BAR proteins control a cur-
rently not well-defined Retro-2-sensitive retrograde trafficking pathway that delivers distinct
nutrients to the bacteria or alternatively could be related to factors controlling innate immuni-
ty. The idea of an innate immunity-related function of the retromer is further supported by the
recently published observation in Drosophila that retromer can also control the Toll pathway
[51].
The observed sensitivity towards the retrograde inhibitor Retro-2 also supports the view
that retrograde transport is important for C. trachomatis progeny formation. The molecular
target of Retro-2 is currently unknown but treatment results in displacement of the three t-
SNAREs syntaxin (Stx) 5, 6 and 16 from membranes of the Golgi apparatus. These t-SNAREs
are essential for retrograde transport of different cargo molecules to the TGN [52]. Interesting-
ly, the localization of Stx6 to the inclusion has also been documented using microscopy and
lack of Stx6 slightly but significantly reduced C. trachomatis infectious progeny [53,54].
Whether the strong inhibitory effect of Retro-2 treatment on C. trachomatis growth and infec-
tious progeny formation is a result of mislocalization of different t-SNAREs from the inclusion
or if additional proteins are also targeted by the treatment remains to be determined.
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Experiments are in progress to address Retro-2 dependent changes on a global level to deter-
mine these factors, which will potentially identify the molecular target of Retro-2 and might
also uncover novel functions of the evolutionarily highly conserved retromer complex.
In summary, we have deciphered the core host cell-derived proteome of the C. trachomatis
inclusion 24 h p.i. by quantitative proteomics of isolated inclusions. This data set describes the
inclusion as a highly complex and interactive compartment that amongst others recruits pro-
teins normally forming the membrane-binding subcomplex of the cellular SNX-BAR retromer.
Of the subset of SNX-BAR proteins, SNX5 controlled the formation of infectious Chlamydia
progeny in a Retro-2 sensitive pathway highlighting the importance of distinct SNX-BAR pro-
teins and the retrograde transport for C. trachomatis infections. Thus, the development of a
technique to isolate Chlamydia inclusions fosters our understanding of the inclusion composi-
tion, the contribution of cellular factors to inclusion formation and maintenance. This may
pave the way for the development of axenic culture conditions and novel anti-chlamydial
strategies.
Materials and Methods
Cell culture, infections and infectious progeny formation
HeLa cells were grown in Roswell Park Memorial Institute medium (RPMI, Gibco) 1640 sup-
plemented with 10% fetal calf serum (FCS, Biochrom) at 37°C and 5% CO2 in a humidified in-
cubator. The cells were routinely tested forMycoplasma contamination via polymerase chain
reaction (PCR) using the VenorGeM kit (Biochrom) according to manufacturer’s instructions.
C. trachomatis L2 lymphatic isolate 434 Bu (ATCC: VR-902B) was propagated in HeLa cells.
For more details on infections, determination of infectious progeny formation, the quantifica-
tion of relative bacterial genome copy number, infection recovery assay, bacterial morphology
assay and measurement of inclusion size, see S1 Text.
Plasmid and siRNA transfections
For plasmid transfections, HeLa cells were grown to 80% confluency and transfected with Lipo-
fectamine 2000 reagent (Invitrogen) according to manufacturer’s instructions. For knockdown
of target host cell proteins, HeLa cells were transfected with pools of target specific siRNAs as
described in S1 Text.
Standard procedures and reagents
For the standard procedures TEM, IF, SDS-PAGE, immunoblotting, molecular cloning as well
as used reagents, plasmids and oligonucleotides, see S1 Text.
Gradient and MACS purification of inclusions
HeLa cells were infected with C. trachomatis (MOI 4) at 70–90% confluence. For standard iso-
lations, 6 x 107 cells were used. All steps were done on ice or in a cold room at 4°C. Cells were
washed once with PBS and subsequently with ice cold HSMG buffer (20 mMHEPES, 250 mM
sucrose, 1.5 mMMgCl2, 0.5 mM EGTA, pH 7.4). Cells were scraped into 6 ml lysis buffer (33%
Percoll solution (Sigma), HSMG) supplemented with cOmplete EDTA free protease inhibitors
(Roche). Lysis was performed by repeated passage through a ball homogenizer (Isobiotech)
using 16 μm clearance and 11–13 passages.
The lysate was then separated on a self-forming Percoll gradient in a total volume of 16 ml
by centrifugation at 35’000 x g for 30 minutes at 4°C (Beckmann RC-6 with Thermo Scientific
F21-8x50y rotor). The lower 6 ml of the gradient were either used for MACS purification or
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crude inclusions were diluted six fold in HSMG and pelleted at 1500 x g for 10 minutes, fol-
lowed by another wash and centrifugation at 1200 x g for 10 minutes.
For MACS separation, crude inclusions were incubated with rabbit αIncA (1:1000) antibody
[55] for 1.5 h at 4°C, followed by incubation with MACS secondary goat anti-rabbit antibody
(1:100, Miltenyi) for another 1.5 hours. Inclusions were mixed gently by inversion every 30
minutes. The crude inclusions were loaded on a MACS LS separation column (Miltenyi) col-
umn in steps of 2 ml and washed with three times the input volume of HSMG buffer. Inclu-
sions were then eluted with 3 ml HSMG buffer after removal of the magnet, aided by gentle
pushing using the supplied plunger. Counting of inclusions, the small scale isolation procedure
for validation and processing of inclusions for IF and TEM are described in supporting infor-
mation (S1 Text).
SILAC experiments
For SILAC experiments, cells were grown in SILAC DMEM (PAA) containing dialyzed FCS
(Biochrom), supplemented with H labeled L-arginine(13C6
15N4) and L-lysine (
13C6
15N2)
(Silantes) or non-labeled amino acids (L). Inclusions were isolated as described above but H la-
beled mock infected cells were mixed with equal amounts with L labeled infected cells prior to
cell lysis. Inclusion samples were prepared for LC-MS/MS. 10% of the sample was used for di-
rect injection after desalting. The remaining peptides were separated by strong anion exchange
chromatography into 6 fractions before desalting, followed by LC-MS/MS. Lysate samples
were prepared for LC-MS/MS without pre-fractionation. For more details, see S1 Text.
Proteome data analysis
Tryptic peptides were analyzed using a data dependent method on a Q Exactive mass spec-
trometer (Thermo) coupled to a Ultimate 3000 nHPLC (Dionex) for separation by reverse
phase chromatography. The resulting. raw files were analyzed in MaxQuant 1.3.0.5 [56]. Pro-
tein groups that had less than two unique + razor peptides in at least one experiment were fil-
tered. See S1 Text for more details on SILAC enrichment analyses, abundance analyses using
iBAQ and further bioinformatics analyses.
Supporting Information
S1 Fig. The inclusion membrane marker IncA sediments to high density fractions in a Per-
coll gradient. A) 6 x 107 HeLa cells were infected with C. trachomatis L2 for 24 h (MOI 2).
Cells were lysed in a ball homogenizer (16 μm clearance, 13 strokes) and subsequently fraction-
ated on an in-situ formed 33% Percoll gradient in HSMG buffer. The gradient was fractionated
into 16 fractions of equal volume (fraction 1: bottom, fraction 16: top). Fractions 1–4 were
pooled, diluted in HSMG and washed twice (P). Equal volumes of each fraction (1–16) or con-
centrated washed inclusions (P) were prepared, separated on a 10% SDS-PAGE gel, western
blotted and probed with specific antibodies against the indicated proteins. B) The majority of
intact inclusions sediments to high density fractions in a Percoll gradient. Intact inclusions
were counted for each fraction of a gradient prepared as described in A) but MOI 3, and the
percentage was plotted. Error bars indicate standard deviation of three independent replicates.
(TIF)
S2 Fig. Statistical test for enrichment in the inclusion fraction/ SILAC exclusion approach.
Proteins were tested for enrichment in the inclusion fraction. The graph shows a bar diagram
with the empirical distribution of the logarithm of the SILAC ratios of proteins that were found
in both the inclusion and lysate fraction. The grey bars indicate the SILAC ratios of proteins
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found in the lysate which overlap with inclusion proteins, blue bars show proteins that are dif-
ferentially enriched in the inclusion fraction. Red bars show proteins which were only found in
inclusion dataset. Proteins enriched in the inclusion fraction are expected to have positive (L/
H) SILAC ratios. A) Proteins of the inclusion fraction which show three SILAC ratios (blue
and red) B) Proteins of the inclusion fraction which only show two SILAC ratios (blue and
red). The highest bar was capped at 500. More proteins were used for the empirical lysate dis-
tribution compared to A, because the overlap for both proteins with two and three SILAC ra-
tios was used.
(TIF)
S3 Fig. Validation of inclusion associated proteins using fluorescent fusion proteins. A) IF
images showing HeLa cells expressing the indicated fluorescent fusion proteins (green), in-
fected with C. trachomatis L2 (MOI 2). Cells were fixed 24 h p.i. with 2% PFA and stained for
IncA (inclusion membrane, red) and DNA (DAPI, blue). Scale bar, 20 μm. B) Validation by
purified inclusions in live cell microscopy. Inclusions were gradient purified from cells express-
ing the indicated fusion protein using a small scale protocol and analyzed by LSCM, DNA was
stained with DAPI. Scale bar, 5 μm. The “results” column indicates whether a protein was con-
sidered to be positively validated (+), not inclusion associated (-) or ambiguous (+-).
(TIF)
S4 Fig. Validation of inclusion associated proteins using immunofluorescence. A) Confocal
immunofluorescence images showing localization of ectopically expressed epitope tagged pro-
teins in C. trachomatis L2 infected cells. HeLa cells were transfected, infected with MOI 2 and
fixed at 24 h p.i. with 2% PFA in PBS, except for FLII-HA which was fixed with ice cold metha-
nol. B) Confocal immunofluorescence images showing localization of endogenous proteins of
interest. HeLa cells were infected with MOI 2 and fixed at 24 h p.i. with 2% PFA in PBS. A) and
B) Cells were stained with indicated antibodies; DNA was stained with DAPI (blue). The re-
sults column indicates whether a protein was considered to be positively validated (+), not in-
clusion associated (-) or ambiguous (+-). Scale bar, 20 μm.
(TIF)
S5 Fig. Localization of retromer components in uninfected cells. A) Confocal immunofluo-
rescence images showing localization of retromer components in uninfected control cells.
HeLa cells were fixed and stained with indicated antibodies; DNA was stained with DAPI
(blue). Scale bar, 5 μm; n = 3. B) Confocal immunofluorescence images showing localization of
eGFP fusion proteins of human SNX5 and SNX6 in uninfected control cells. HeLa cells were
transfected, fixed and stained with indicated antibodies; DNA was stained with DAPI (blue).
Scale bar, 10 μm; n = 2.
(TIF)
S6 Fig. Co-localization of SNX3/VPS35 and SNX12/VPS25. Confocal immunofluorescence
images showing co-localization of A) eGFP-SNX3 with endogenous VPS35 and B)
eGFP-SNX12 with endogenous VPS35 in C. trachomatis L2 infected (Ctr L2, MOI 2) and unin-
fected (NI) HeLa cells. HeLa cells were infected 4 h prior to transfection, fixed at 24 h p.i. and
stained with indicated antibodies; DNA was stained with DAPI (blue). Scale bar, 10 μm; n = 2.
(TIF)
S7 Fig. Co-localization of SNX2/VPS35. A) Quantification of SNX2/VPS35 co-localization
indicating Pearson’s correlation coefficient (r) in C. trachomatis L2 infected (Ctr L2, MOI 2) in-
fected and uninfected cells either expressing eGFP-SNX2 or VPS35-eGFP. Correlation of the
two signals was analyzed and quantified using ZEN 2010 software (Zeiss) in either the
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complete cell area (total), the cytoplasmic area of infected cells excluding the inclusion (cyto-
plasm) or directly at the inclusion (inclusion) (n = 2; error bars, SE). B) Confocal immunofluo-
rescence images showing co-localization of eGFP-VPS35 fusion protein with endogenous
SNX2 in C. trachomatis L2 infected (Ctr L2, MOI 2) and uninfected (NI) HeLa cells. HeLa cells
were infected 4 h prior to transfection, fixed at 24 h p.i. and stained with indicated antibodies;
DNA was stained with DAPI (blue). Scale bar, 10 μm; n = 2.
(TIF)
S8 Fig. siRNA knockdown control. A) Immunoblot analysis of single siRNA knockdowns of
retromer components in C. trachomatis L2 infected (Ctr L2, MOI 0.5) HeLa cells. n = 3. B) Re-
infection assay assessing the effect of combinational SNXs knockdown on infectious progeny
formation 48 h p.i. (n = 3; error bars, SE). C) Western blot analysis of combinational siRNA
knockdowns of retromer components in C. trachomatis L2 infected (Ctr L2, MOI 0.5) HeLa
cells. β-actin was used as loading control; n = 3.
(TIF)
S9 Fig. Recruitment of SNX1, SNX2, eGFP-SNX5 and eGFP-SNX6 to the inclusion. Confo-
cal IF images showing localization of SNX1, SNX2, eGFP-SNX5 and eGFP-SNX6 during C. tra-
chomatis L2 infection (MOI 2) at 8 h, 12 h, 16 h, 20 h and 24 h p.i. and in uninfected HeLa
cells. Cells were stained with indicated antibodies; DNA was stained with DAPI (blue). Images
show maximum intensity projections of z-stacks. Scale bar, 10 μm; n = 2.
(TIF)
S10 Fig. Retro-2 treatment at 20 h p.i. reduces infectious progeny formation. Reinfection
assays assessing the effect of Retro-2 on infectious progeny formation. HeLa cells were infected
with C. trachomatis L2 (MOI 2) and, at 8 h p.i., or 24 h p.i., cells were either treated with indi-
cated concentrations of Retro-2 or DMSO. Cells were harvested and inclusion forming units
(IFU) per ml were determined at 48 h p.i. (n = 3; error bars, SE;  indicates p value< 0.005).
(TIF)
S11 Fig. Retro-2 treatment results in smaller inclusions with regular shape. The size and
number of inclusions was assessed by immunofluorescence microscopy. HeLa cells were in-
fected with C. trachomatis (MOI 0.5). Retro-2 or DMSO was added at 8 h p.i. Cells were fixed
with 2% PFA in PBS at the indicated time point. Immunostaining was performed against bacte-
rial Hsp60 and epifluorescence microscopy pictures were randomly taken at an AxioVert40 in-
verted microscope. A) A script in ImageJ software was used to count the relative numbers and
measure the area of inclusions. Asterisk indicates a p value below 0.05. B) Representative image
of Retro-2 and DMSO treated cells at 24 h p.i. Scale bar = 100 μm.
(TIF)
S12 Fig. Morphology analysis of Retro-2 treated HeLa cells.HeLa cells were infected for 48 h
with C. trachomatis L2 (MOI 2). The cells were treated with 20 μM Retro-2 at 8 h p.i. or mock
treated with DMSO. Cells were pelleted and fixed with glutaraldehyde before processing for
TEM. Randomized images were taken from slices and the images were analyzed by eye for the
distribution of different morphologies of C. trachomatis. G = ghost, IB = intermediate body,
RB = reticulate body, EB = elementary body; n = 3; bars indicate SE.
(TIF)
S13 Fig. Effect of Retro-2 treatment on the localization of SNX1, SNX2, eGFP-SNX5 and
eGFP-SNX6 during C. trachomatis infection. Confocal IF images showing localization of
SNX1, SNX2, eGFP-SNX5 and eGFP-SNX6 during C. trachomatis L2 infection (MOI 2) at 12
h (SNX1, SNX2 and eGFP-SNX5), 16 h (eGFP-SNX6) and 24 h p.i. treated with indicated
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concentrations of Retro-2 or DMSO as solvent control. Cells were stained with indicated anti-
bodies; DNA was stained with DAPI (blue). Images show maximum intensity projections of z-
stacks. Scale bar, 10 μm; n = 2.
(TIF)
S14 Fig. Known inclusion associated proteins by abundance in cell lysate. Previously re-
ported inclusion associated proteins were ranked by their abundance in HeLa cell lysates based
on iBAQ intensity of tryptic peptides [22]. Proteins that were not found in the lysate are on the
detection limit (rank 8604, n = 5). Positive = proteins that passed the SILAC exclusion ap-
proach, Excluded = did not pass the SILAC exclusion approach or were removed by initial fil-
tering of common contaminants. Not in triplicate = proteins detected in the inclusion fraction
but not in all experiments. Not found = proteins that were never detected in the inclusion frac-
tion. Too few peptides = proteins that were identified in all three experiments but with only
one peptide.
(TIF)
S15 Fig. Distribution of protein annotation terms in lysate and inclusion proteomes. Pro-
teins that were reliably found and quantified in the inclusion and the total cell lysate (Lysate:
n = 2002; Inclusion: n = 351) were annotated with subcellular localization data from Uni-
protKB. The percentage of proteins annotated with the indicated term is shown. One protein
can have annotations for several organelles.
(TIF)
S1 Text. Supplemental experimental procedures with references.
(DOCX)
S1 Table. Inclusion associated host proteins. Protein ID = Uniprot ID of the first protein of
the Majority protein column of a protein group. Majority protein groups identified in Lysates
and Inclusion fractions are listed in the respective columns. Relative SD = standard deviation
of the indicated percentage/ratio divided by mean (coefficient of variation). PEP
Score = Posterior Error Probability as reported by MaxQuant. Inclusion SILAC L/H
AVG = average of SILAC ratios in the inclusion fraction. SILAC enrichment analysis set = test
performed with three (1) or two (2) SILAC ratios. Log2(iBAQ Enrichment) = log2 transformed
iBAQ enrichment score as described in S1 Text; calculation of the relative abundance of the
protein in the inclusion fraction relative to its relative abundance in the total cell lysate.
Peptides = number of Razor + Unique peptides identified in each experiment. Inclusion Quan-
tification Qualifier = 1 if relative SD below 0.5. Lysate Quantification Qualifier: 0 = quantified
on the basis of one experiment; 1 = quantified in all three experiments with two or more pep-
tides and relative SD below 0.5; as (1) but less than two peptides in one experiment; 3 = as 2 but
only in found in two of three experiments;— = relative SD above 0.5; N = quantified based on
dataset from Nagaraj et al. 2011 [31].
(XLSX)
S2 Table. Overview of proteins that associate with the inclusion of C. trachomatis at 24 h p.
i. with references. Trivial names were used as reported in the cited manuscripts. The Uniprot
identifier (ID) of the reviewed human protein is shown for each protein except for actin where
the exact proteins were not defined. ISO indicates if a highly homologous variant was found.
(DOCX)
S3 Table. Gene Ontology enrichment analysis of biological processes. Output of enrichment
analysis as obtained from GOrilla [57]. Table legend as supplied by GOrilla: 'P-value' is the en-
richment p value computed according to the mHG or HG model. This p value is not corrected
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for multiple testing of 9401 GO terms. 'FDR q-value' is the correction of the above p value for
multiple testing using the Benjamini and Hochberg method. Namely, for the ith term (ranked
according to p value) the FDR q-value is (p value  number of GO terms) / i. Enrichment (N, B,
n, b) is defined as follows: N—is the total number of genes B—is the total number of genes as-
sociated with a specific GO term n—is the number of genes in the top of the user's input list or
in the target set when appropriate b—is the number of genes in the intersection. Enrichment =
(b/n) / (B/N). Genes: For each GO term you can see the list of associated genes that appear in
the optimal top of the list. Each gene name is specified by gene symbol followed by a short de-
scription of the gene.
(XLSX)
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